{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:20:31Z","timestamp":1785903631831,"version":"3.56.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11239-022-02677-7","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T06:10:56Z","timestamp":1657692656000},"page":"255-259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Systemic bevacizumab as salvage therapy for persistent severe bleeding and anemia in heyde syndrome following aortic valve replacement"],"prefix":"10.1007","volume":"54","author":[{"given":"Zain M.","family":"Virk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef R.","family":"Badran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6175-1383","authenticated-orcid":false,"given":"Hanny","family":"Al-Samkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"issue":"11","key":"2677_CR1","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1053\/j.jvca.2020.10.003","volume":"35","author":"S Mondal","year":"2021","unstructured":"Mondal S, Hollander KN, Ibekwe SO, Williams B, Tanaka K (2021) Heyde syndrome-pathophysiology and perioperative implications. J Cardiothorac Vasc Anesth 35(11):3331\u20133339. https:\/\/doi.org\/10.1053\/j.jvca.2020.10.003","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"2","key":"2677_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1182\/blood-2018-01-769018","volume":"32","author":"AM Randi","year":"2018","unstructured":"Randi AM, Smith KE, Castaman G (2018) Von willebrand factor regulation of blood vessel formation. Blood 32(2):132\u2013140. https:\/\/doi.org\/10.1182\/blood-2018-01-769018","journal-title":"Blood"},{"issue":"1","key":"2677_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jtcvs.2011.05.034","volume":"144","author":"JL Thompson","year":"2012","unstructured":"Thompson JL, Schaff HV, Dearani JA, Park SJ, SundtSuri TMRM et al (2012) Risk of recurrent gastrointestinal bleeding after aortic valve replacement in patients with heyde syndrome. J Thorac Cardiovasc Surg 144(1):112\u2013116. https:\/\/doi.org\/10.1016\/j.jtcvs.2011.05.034","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"8","key":"2677_CR4","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.3324\/haematol.2020.261859","volume":"106","author":"H Al-Samkari","year":"2021","unstructured":"Al-Samkari H, Kasthuri RS, Parambil JG, Albitar HA, Almodallal YA, V\u00e1zquez C et al (2021) An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-bleed study. Haematologica 106(8):2161\u20132169. https:\/\/doi.org\/10.3324\/haematol.2020.261859","journal-title":"Haematologica"},{"key":"2677_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omy134","author":"E Omar Then","year":"2019","unstructured":"Omar Then E, Catalano C, Sunkara T, Gaduputi V (2019) New onset heyde\u2019s syndrome presenting after total aortic valve replacement. Oxf Med Case Rep. https:\/\/doi.org\/10.1093\/omcr\/omy134","journal-title":"Oxf Med Case Rep"},{"issue":"3","key":"2677_CR6","first-page":"291","volume":"53","author":"GD De Palma","year":"2007","unstructured":"De Palma GD, Salvatori F, Masone S, Simeoli I, Rega M, Celiento M et al (2007) Acute gastrointestinal bleeding following aortic valve replacement in a patient with heyde\u2019s sindrome. Case Rep Minerva Gastroenterol Dietol 53(3):291\u2013293","journal-title":"Case Rep Minerva Gastroenterol Dietol"},{"issue":"6","key":"2677_CR7","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/hae.14034","volume":"26","author":"H Al-Samkari","year":"2020","unstructured":"Al-Samkari H, Albitar HA, Olitsky SE, Clancy MS, Iyer VN (2020) An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia. Haemoph Off J World Fed Hemoph 26(6):1038\u20131045. https:\/\/doi.org\/10.1111\/hae.14034","journal-title":"Haemoph Off J World Fed Hemoph"},{"issue":"1","key":"2677_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s13023-019-1239-6","volume":"14","author":"H Al-Samkari","year":"2019","unstructured":"Al-Samkari H, Albitar HA, Olitsky SE, Clancy MS, Iyer VN (2019) Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers. Orphanet J Rare Dis 14(1):256. https:\/\/doi.org\/10.1186\/s13023-019-1239-6","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2677_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/joim.12832","volume":"285","author":"H Al-Samkari","year":"2019","unstructured":"Al-Samkari H, Kritharis A, Rodriguez-Lopez JM, Kuter DJ (2019) Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia. J Intern Med 285(2):223\u2013231. https:\/\/doi.org\/10.1111\/joim.12832","journal-title":"J Intern Med"},{"issue":"9","key":"2677_CR10","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3324\/haematol.2018.193003","volume":"103","author":"A Kritharis","year":"2018","unstructured":"Kritharis A, Al-Samkari H, Kuter DJ (2018) Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist\u2019s perspective. Haematologica 103(9):1433\u20131443. https:\/\/doi.org\/10.3324\/haematol.2018.193003","journal-title":"Haematologica"},{"issue":"2","key":"2677_CR11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1177\/0194599818813521","volume":"160","author":"H Al-Samkari","year":"2019","unstructured":"Al-Samkari H (2019) Systemic bevacizumab for hereditary hemorrhagic telangiectasia: considerations from observational studies. Otolaryngol-Head Neck Surg 160(2):368. https:\/\/doi.org\/10.1177\/0194599818813521","journal-title":"Otolaryngol-Head Neck Surg"},{"issue":"19","key":"2677_CR12","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1182\/bloodadvances.2021004810","volume":"5","author":"AB Song","year":"2021","unstructured":"Song AB, Sakhuja R, Gracin NM, Weinger R, Kasthuri RS, Al-Samkari H (2021) Systemic bevacizumab for refractory bleeding and transfusion-dependent anemia in heyde syndrome. Blood Adv 5(19):3850\u20133854. https:\/\/doi.org\/10.1182\/bloodadvances.2021004810","journal-title":"Blood Adv"},{"issue":"5","key":"2677_CR13","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1203\/01.pdr.0000242494.94000.52","volume":"60","author":"L Segerstr\u00f6m","year":"2006","unstructured":"Segerstr\u00f6m L, Fuchs D, B\u00e4ckman U, Holmquist K, Christofferson R, Azarbayjani F (2006) The anti-VEGF antibody bevacizumab potently reduces the growth rate of high-risk neuroblastoma xenografts. Pediatr Res 60(5):576\u2013581. https:\/\/doi.org\/10.1203\/01.pdr.0000242494.94000.52","journal-title":"Pediatr Res"},{"issue":"31","key":"2677_CR14","doi-asserted-by":"publisher","first-page":"8136","DOI":"10.1200\/JCO.2005.02.5635","volume":"23","author":"CG Willett","year":"2005","unstructured":"Willett CG, Boucher Y, Duda DG, di Tomaso E, Munn LL, Tong RT et al (2005) Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol Off 23(31):8136\u20138139. https:\/\/doi.org\/10.1200\/JCO.2005.02.5635","journal-title":"J Clin Oncol Off"},{"issue":"5","key":"2677_CR15","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa021491","volume":"349","author":"JC Yang","year":"2003","unstructured":"Yang JC, Haworth L, Sherry RM, Hwu P, Schwartzentruber DJ, Topalian SL et al (2003) A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 349(5):427\u2013434. https:\/\/doi.org\/10.1056\/NEJMoa021491","journal-title":"N Engl J Med"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-022-02677-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-022-02677-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-022-02677-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T07:12:43Z","timestamp":1660029163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-022-02677-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2677"],"URL":"https:\/\/doi.org\/10.1007\/s11239-022-02677-7","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]},"assertion":[{"value":"19 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}